VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditions.

Scientific Reports
Osheiza AbdulmalikMartin K Safo

Abstract

Sickle cell disease (SCD) results from a hemoglobin (Hb) mutation βGlu6 → βVal6 that changes normal Hb (HbA) into sickle Hb (HbS). Under hypoxia, HbS polymerizes into rigid fibers, causing red blood cells (RBCs) to sickle; leading to numerous adverse pathological effects. The RBC sickling is made worse by the low oxygen (O2) affinity of HbS, due to elevated intra-RBC concentrations of the natural Hb effector, 2,3-diphosphoglycerate. This has prompted the development of Hb modifiers, such as aromatic aldehydes, with the intent of increasing Hb affinity for O2 with subsequent prevention of RBC sickling. One such molecule, Voxelotor was recently approved by U.S. FDA to treat SCD. Here we report results of a novel aromatic aldehyde, VZHE-039, that mimics both the O2-dependent and O2-independent antisickling properties of fetal hemoglobin. The latter mechanism of action-as elucidated through crystallographic and biological studies-is likely due to disruption of key intermolecular contacts necessary for stable HbS polymer formation. This dual antisickling mechanism, in addition to VZHE-039 metabolic stability, has translated into significantly enhanced and sustained pharmacologic activities. Finally, VZHE-039 showed no significant in...Continue Reading

References

Sep 1, 1976·British Medical Bulletin·M F Perutz
Jan 1, 1990·Advances in Protein Chemistry·W A Eaton, J Hofrichter
Sep 1, 1986·Archives of Biochemistry and Biophysics·W N PoillonJ A Walder
Feb 28, 1983·Biochemical and Biophysical Research Communications·M D RhodaJ Rosa
Feb 1, 1995·Protein Engineering·A C WallaceJ M Thornton
Apr 1, 1995·British Journal of Clinical Pharmacology·P E RolanJ Posner
Apr 5, 1993·Journal of Molecular Biology·I Cretegny, S J Edelstein
Nov 5, 1997·Journal of Molecular Biology·D J HarringtonW E Royer
Mar 7, 1998·European Journal of Biochemistry·A YoshidaC Chang
Jul 1, 1998·Annual Review of Biophysics and Biomolecular Structure·M F PerutzG G Dodson
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Jun 22, 1999·Journal of Toxicology and Environmental Health. Part a·V B GodfreyL T Burka
Jan 13, 2001·Chemico-biological Interactions·V VasiliouD R Petersen
Jan 25, 2003·Blood·John D BelcherGregory M Vercellotti
Jul 29, 2004·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Frank A Ferrone
Feb 3, 2005·British Journal of Haematology·Osheiza AbdulmalikToshio Asakura
May 24, 2005·International Journal of Pharmaceutics·Anthony M MarinoPraveen V Balimane
Sep 30, 2005·The Journal of Pharmacology and Experimental Therapeutics·R Scott ObachLarry M Tremaine
Mar 11, 2006·Blood·Vladan P CokicAlan N Schechter
Sep 26, 2008·Chemistry & Biodiversity·Ijeoma N NnamaniMartin K Safo
Jan 21, 2009·Acta Crystallographica. Section D, Biological Crystallography·Joy D JenkinsMartin K Safo
Mar 31, 2010·Pathology·Genia Burchall, Ellen Maxwell
Jun 26, 2010·Journal of Cellular Physiology·Idowu Akinsheye, Elizabeth S Klings
Dec 21, 2010·Nature Medicine·Yujin ZhangYang Xia
Mar 15, 2011·Biochimica Et Biophysica Acta·Martin K SafoTelih Boyiri
Aug 9, 2011·Methods : a Companion to Methods in Enzymology·Paul D AdamsPeter H Zwart
Nov 22, 2011·Acta Crystallographica. Section D, Biological Crystallography·Osheiza AbdulmalikMartin K Safo
Jun 8, 2012·Journal of Applied Crystallography·Nathaniel EcholsPaul D Adams
Mar 5, 2014·Hematology/oncology Clinics of North America·Martin K Safo, Gregory J Kato
May 20, 2014·The Journal of Clinical Investigation·Yujin ZhangYang Xia
Apr 18, 2016·Journal of Structural Biology·Mohini S GhatgeMartin K Safo
Dec 14, 2016·The New England Journal of Medicine·Kenneth I AtagaRussell P Rother
Mar 25, 2017·ACS Medicinal Chemistry Letters·Brian MetcalfZhe Li
Apr 20, 2017·The New England Journal of Medicine·Frédéric B PielDavid C Rees
Nov 19, 2017·American Journal of Hematology·Robert P Hebbel, Bo E Hedlund
Apr 16, 2018·Bioorganic & Medicinal Chemistry·Piyusha P PagareMartin K Safo
Apr 18, 2018·Clinical Hemorheology and Microcirculation·Kobina DufuPedro Cabrales
Oct 6, 2018·Acta Crystallographica. Section D, Structural Biology·Tanvi M DeshpandeMartin K Safo
Dec 6, 2018·Nature Reviews. Drug Discovery·Marilyn J TelenGregory M Vercellotti
Jan 30, 2019·Experimental Biology and Medicine·Nicola Conran, Lidiane Torres

❮ Previous
Next ❯

Methods Mentioned

BETA
x-ray diffraction

Software Mentioned

Prism Graph Pad
trek
LigPlus
Image Capture
Hemox Analyzer
Scientist
Phenix
Pymol Molecular Graphics System
LIGPLOT
Voxelotor

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.